ArticleThe Journal of allergy and clinical immunology2008
IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.
Article in The Journal of allergy and clinical immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01276522 (Efficacy and Safety of Canakinumab in Schnitzler Syndrome), which is not on this map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Efficacy and Safety of Canakinumab in Schnitzler Syndrome
Who cites it
31 citing papers in PubMed.
- Schnitzler syndrome.Dermatologie (Heidelberg, Germany) · 2025Review
- [The most frequent febrile syndromes and autoinflammatory diseases in adulthood].Zeitschrift fur Rheumatologie · 2024Review
- Cutaneous manifestations of monoclonal gammopathy.Blood cancer journal · 2022Review
- Case Report: Therapeutic Use of Ibrutinib in a Patient With Schnitzler Syndrome.Frontiers in immunology · 2022Article
- [Clinical symptoms of autoinflammatory diseases].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2020Review
- Cytokine Signature in Schnitzler Syndrome: Proinflammatory Cytokine Production Associated to Th Suppression.Frontiers in immunology · 2020Article
- Hereditary systemic autoinflammatory diseases and Schnitzler's syndrome.Rheumatology (Oxford, England) · 2019Review
- [Schnitzler syndrome].Zeitschrift fur Rheumatologie · 2019Article
- [Schnitzler syndrome].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2018Article
- Increasing the Interval of Canakinumab Administration Effectively Supports the Remission of Schnitzler's Syndrome.Case reports in rheumatology · 2018Article
- Anakinra Therapy for Non-cancer Inflammatory Diseases.Frontiers in pharmacology · 2018Review
- Schnitzler Syndrome: a Review.Current rheumatology reports · 2017Review
- Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.Rheumatology (Oxford, England) · 2015Review
- The role of interleukin-1 beta in the pathophysiology of Schnitzler's syndrome.Arthritis research & therapy · 2015Article
- Schnitzler's syndrome: lessons from 281 cases.Clinical and translational allergy · 2014Review
- Treating inflammation by blocking interleukin-1 in humans.Seminars in immunology · 2013Review
- Effect of in vitro and in vivo anakinra on cytokines production in Schnitzler syndrome.PloS one · 2013Article
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.Nature reviews. Drug discovery · 2012Review
- [Schnitzler syndrome].Zeitschrift fur Rheumatologie · 2012Review
- Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.Clinical and experimental immunology · 2012Review
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
17936890What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.